Cytochrome P450 2D6 (CYP2D6) and glucose-6-phosphate dehydrogenase (G6PD) genetic variations in Thai vivax malaria patients: Implications for 8-aminoquinoline radical cure
Background Primaquine and tafenoquine are the only licensed drugs that effectively kill the hypnozoite stage and are used to prevent Plasmodium vivax malaria relapse. However, both primaquine and tafenoquine can cause acute hemolysis in glucose-6-phosphate dehydrogenase (G6PD)-deficient people with...
Saved in:
Main Author: | Chamchoy K. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/87157 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Cloning of cytochrome P450, CYP6P5, and CYP6AA2 from Anopheles minimus resistant to deltamethrin
by: Pornpimol Rongnoparut, et al.
Published: (2018) -
Genotype-phenotype association and biochemical analyses of glucose-6-phosphate dehydrogenase variants: Implications for the hemolytic risk of using 8-aminoquinolines for radical cure
by: Sudsumrit S.
Published: (2023) -
MOLECULAR ANALYSIS FOR THE DETECTION OF GLUCOSE 6- PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY
by: Perpustakaan UGM, i-lib
Published: (2001) -
G-6-PD intanon - A new glucose-6-phosphate dehydrogenase variant
by: Vicharn Panich
Published: (2018) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
by: Taylor W.R.J.
Published: (2023)